Mr Angus McNamara

Grant-Funded Researcher (A)

School of Pharmacy and Biomedical Science

College of Health


I am a grant-funded post-doctoral researcher in the Cognition, Ageing and Neurodegenerative Diseases Laboratory at the University of Adelaide. Completing my PhD in 2024, my research focuses on the incorporation of biological assessments to forecast disease course and trajectory of motor and non-motor outcomes in Parkinson's Disease, as well their potential role to streamline early diagnosis. To this end, I am involved in projects assessing neurodegeneration and disease risk in at-risk groups, such as individuals with a history of traumatic brain injury and pesticide exposure.

Date Position Institution name
2024 - ongoing Post-Doctoral Researcher University of Adelaide

Language Competency
English Can read, write, speak, understand spoken and peer review

Date Institution name Country Title
2021 - 2024 University of Adelaide Australia PhD
2020 - 2020 University of Adelaide Australia Bachelor of Health and Medical Sciences (Honours), Major in Anatomical Sciences
2017 - 2019 University of Adelaide Australia Bachelor of Health and Medical Sciences (Advanced), Major in Neuroscience

Year Citation
2025 McNamara, A., Baetu, I., & Collins-Praino, L. (2025). History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts.. Eur J Neurol, 32(3), e70090.
DOI
2025 Ellul, B., McNamara, A., Laurenz, S., Baetu, I., Jenkinson, M., & Collins-Praino, L. E. (2025). Predicting Cognition and Affective Changes in Newly Diagnosed Parkinson’s Disease Through Longitudinal Data-Driven Clustering. Journal of Geriatric Psychiatry and Neurology, 17 pages.
DOI Scopus1 WoS1 Europe PMC1
2025 McNamara, A., Ellul, B. P., Baetu, I., Jenkinson, M., Lau, S., & Collins-Praino, L. (2025). Utility of Baseline Pathological, Neuroimaging and Clinical Markers for Prognosis in Early Parkinson's Disease.. J Geriatr Psychiatry Neurol, 8919887251397641.
DOI
2022 Guglietti, B., Hobbs, D. A., Wesson, B., Ellul, B., McNamara, A., Drum, S., & Collins-Praino, L. E. (2022). Development and Co-design of NeuroOrb: A Novel "Serious Gaming" System Targeting Cognitive Impairment in Parkinson's Disease.. Frontiers in aging neuroscience, 14(728212), 1-18.
DOI Scopus6 WoS5 Europe PMC3

Year Citation
2024 Collins-Praino, L., McNamara, A., Ellul, B., Baetu, I., Lau, S., & Jenkinson, M. (2024). Beyond Clinical Presentation: Incorporating Neuroimaging and Biofluid Markers to Predict Progression of Parkinson's disease (PD). In MOVEMENT DISORDERS Vol. 39 (pp. S63-S64). PA, Philadelphia: WILEY.

Year Citation
2023 McNamara, A., Ellul, B., Baetu, I. -I., Lau, S., Jenkinson, M., & Collins-Praino, L. (2023). Utility of Baseline Pathological, Neuroimaging and Clinical Markers for Progression Prognosis and Subtype Classification in Early Parkinson's Disease: Implications for Cognitive Impairment. Poster session presented at the meeting of Abstracts of the Alzheimer's Association International Conference (AAIC 2023), as published in Alzheimer's & Dementia Journal. Amsterdam, The Netherlands: Wiley.
DOI
2023 McNamara, A., Ellul, B., Baetu, I. -I., Lau, S., Jenkinson, M., & Collins-Praino, L. (2023). Predicting progression of Parkinson’s disease motor outcomes using a multimodal combination of baseline clinical measures, neuroimaging and biofluid markers. Poster session presented at the meeting of Abstracts of the 6th World Parkinson Congress, as published in Journal of Parkinson's Disease. Barcelona, Spain: IOS Press.
DOI
2023 Ellul, B., McNamara, A., Baetu, I., Lau, S., Jenkinson, M., & Collins-Praino, L. (2023). Predicting longitudinal cognition and mood changes in newly diagnosed Parkinson's Disease from substantia nigra imaging (Oral Presentation). Poster session presented at the meeting of ACNS Conference Sydney 2023. https://drive.google.com/drive/folders/1Ixovo4O6LZNfSrf4S0Ds6vkbmyayHHEt.
2022 McNamara, A., Ellul, B., Baetu, I., Lau, S., Jenkinson, M., & Collins-Praino, L. (2022). Predicting Progression of Parkinson’s Disease Motor Outcomes Using a Multimodal Combination of Baseline Clinical Measures, Neuroimaging and Biofluid Markers in Early PD. Poster session presented at the meeting of Australasian Neuroscience Conference 2022. Melbourne.
2022 Ellul, B., McNamara, A., Baetu, I., Lau, S., Jenkinson, M., & Collins-Praino, L. (2022). The role of the substantia nigra in predicting longitudinal cognitive and mood changes in newly diagnosed Parkinson’s Disease. Poster session presented at the meeting of Australasian Neuroscience Conferences 2022. Melbourne, Australia.

Date Role Research Topic Location Program Supervision Type Student Load Student Name
2025 - ongoing Co-Supervisor Investigating White Matter Microstructural Alterations Associated with Mood Dysfunction Following Traumatic Brain Injury University of Adelaide - Honours Full Time Yaroslava Leonova
2024 - ongoing Co-Supervisor Characterising the Burden of Prodromal Parkinson’s Disease Symptoms after Traumatic Brain Injury and its Association with Substantia Nigra Volume University of Adelaide - Honours Part Time Silas Hansch-Maher

Connect With Me

External Profiles

Other Links